{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:10:04Z","timestamp":1778937004354,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R345\\u20132020-1977"],"award-info":[{"award-number":["R345\\u20132020-1977"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jmccpl.2025.100300","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:24:44Z","timestamp":1746062684000},"page":"100300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Independent and synergistic roles of MEK-ERK1\/2 and PKC pathways in regulating functional changes in vascular tissue following flow cessation"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-7132","authenticated-orcid":false,"given":"Spyridoula","family":"Kazantzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-1346","authenticated-orcid":false,"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-8957","authenticated-orcid":false,"given":"Kristian Agmund","family":"Haanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2202-9-85","article-title":"Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK\/ERK pathway","volume":"9","author":"Maddahi","year":"2008","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/157016109787354178","article-title":"Cerebrovascular endothelin receptor upregulation in cerebral ischemia","volume":"7","author":"Edvinsson","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"issue":"7","key":"10.1016\/j.jmccpl.2025.100300_bb0015","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/jcbfm.2011.70","article-title":"Vascular plasticity in cerebrovascular disorders","volume":"31","author":"Edvinsson","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid haemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0025","doi-asserted-by":"crossref","unstructured":"Liu, S., et al., Endothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein βγ Subunit Signaling to Protein Kinase B\/Akt *. J Biol Chem, 2003. 278(50): p. 49929\u201349935.","DOI":"10.1074\/jbc.M306930200"},{"issue":"1\u20133","key":"10.1016\/j.jmccpl.2025.100300_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2007.09.031","article-title":"Endothelin receptor-mediated vasodilatation: effects of organ culture","volume":"579","author":"Nilsson","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.jmccpl.2025.100300_bb0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/CS20190124","article-title":"Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction","volume":"134","author":"Bautista-Ni\u00f1o","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.jmccpl.2025.100300_bb0040","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1111\/bph.12606","article-title":"Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion","volume":"171","author":"Skovsted","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"13\u201314","key":"10.1016\/j.jmccpl.2025.100300_bb0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.lfs.2012.02.009","article-title":"Rapid functional upregulation of vasocontractile endothelin ETB receptors in rat coronary arteries","volume":"91","author":"Skovsted","year":"2012","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100300_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00221-012-3108-6","article-title":"In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries","volume":"219","author":"Povlsen","year":"2012","journal-title":"Exp Brain Res"},{"issue":"9","key":"10.1016\/j.jmccpl.2025.100300_bb0055","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/01.STR.0000028183.04277.32","article-title":"Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat","volume":"33","author":"Stenman","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2261-8-21","article-title":"Up-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathways","volume":"8","author":"Nilsson","year":"2008","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100300_bb0065","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.STR.0000072984.79136.79","article-title":"Intracellular Pathways Involved in Upregulation of Vascular Endothelin Type B Receptors in Cerebral Arteries of the Rat","volume":"34","author":"Henriksson","year":"2003","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jmccpl.2025.100300_bb0070","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0705803","article-title":"Importance of ERK1\/2 in upregulation of endothelin type B receptors in cerebral arteries","volume":"142","author":"Henriksson","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2010.06.053","article-title":"Comparison of MEK\/ERK pathway inhibitors on the upregulation of vascular G-protein coupled receptors in rat cerebral arteries","volume":"644","author":"Sandhu","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.jmccpl.2025.100300_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107728","article-title":"Protein kinase C-inhibition reduces critical weight loss and improves functional outcome after experimental subarachnoid haemorrhage","volume":"33","author":"B\u00f6mers","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"10.1016\/j.jmccpl.2025.100300_bb0085","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/ph15121446","article-title":"The MEK Inhibitor Trametinib Improves Outcomes following Subarachnoid Haemorrhage in Female Rats","volume":"15","author":"B\u00f6mers","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"16","key":"10.1016\/j.jmccpl.2025.100300_bb0090","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1042\/CS20190636","article-title":"Pre-clinical effects of highly potent MEK1\/2 inhibitors on rat cerebral vasculature after organ culture and subarachnoid haemorrhage","volume":"133","author":"Christensen","year":"2019","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0095","first-page":"23","article-title":"Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1\/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo","volume":"39","author":"Yamaguchi","year":"2011","journal-title":"Int J Oncol"},{"issue":"11","key":"10.1016\/j.jmccpl.2025.100300_bb0100","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acs.jmedchem.5b00466","article-title":"Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1\/2","volume":"58","author":"Ward","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0105","doi-asserted-by":"crossref","unstructured":"Wilkinson, S.E., P.J. Parker, and J.S. Nixon, Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J, 1993. 294 ( Pt 2)(Pt 2): p. 335\u20137.","DOI":"10.1042\/bj2940335"},{"issue":"3","key":"10.1016\/j.jmccpl.2025.100300_bb0110","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1074\/jbc.M209677200","article-title":"BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice","volume":"278","author":"Burke","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1748-1716.1983.tb07178.x","article-title":"Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels","volume":"117","author":"H\u00f6gest\u00e4tt","year":"1983","journal-title":"Acta Physiol Scand"},{"issue":"1\u20133","key":"10.1016\/j.jmccpl.2025.100300_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2010.04.006","article-title":"NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries","volume":"637","author":"Zheng","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100300_bb0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000153247","article-title":"Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1\/2, p38\/NF-kappaB pathways","volume":"46","author":"Zhang","year":"2009","journal-title":"J Vasc Res"},{"issue":"10","key":"10.1016\/j.jmccpl.2025.100300_bb0130","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1161\/STR.0000000000000074","volume":"46","author":"Powers","year":"2015","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1941874419870701","article-title":"A New Era of Extended Time Window Acute Stroke Interventions Guided by Imaging","volume":"10","author":"Rehani","year":"2020","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0140","doi-asserted-by":"crossref","first-page":"1010092","DOI":"10.3389\/fendo.2022.1010092","article-title":"PKC-mediated phosphorylation and activation of the MEK\/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer","volume":"13","author":"Scerri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"38","key":"10.1016\/j.jmccpl.2025.100300_bb0145","doi-asserted-by":"crossref","first-page":"23512","DOI":"10.1074\/jbc.271.38.23512","article-title":"Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf","volume":"271","author":"Ueda","year":"1996","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100300_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2159-8290.CD-17-1119","article-title":"First-in-Class ERK1\/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study","volume":"8","author":"Sullivan","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216012","article-title":"ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma","volume":"554","author":"Song","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0160","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/bs.apha.2024.04.001","article-title":"Chapter Five - Progress in the development of ERK1\/2 inhibitors for treating cancer and other diseases","author":"Grogan","year":"2024"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0165","first-page":"70","article-title":"ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework. npj Precision","volume":"8","author":"Timofeev","year":"2024","journal-title":"Oncology"},{"issue":"45","key":"10.1016\/j.jmccpl.2025.100300_bb0170","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1039\/C8SC02754D","article-title":"Quantitation of ERK1\/2 inhibitor cellular target occupancies with a reversible slow off-rate probe","volume":"9","author":"Lebraud","year":"2018","journal-title":"Chem Sci"},{"issue":"3","key":"10.1016\/j.jmccpl.2025.100300_bb0175","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/jcb.29457","article-title":"Vascular endothelial growth factor enhances tendon-bone healing by activating Yes-associated protein for angiogenesis induction and rotator cuff reconstruction in rats","volume":"121","author":"Huang","year":"2020","journal-title":"J Cell Biochem"},{"issue":"39","key":"10.1016\/j.jmccpl.2025.100300_bb0180","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1038\/onc.2013.555","article-title":"Combined PKC and MEK inhibition for treating metastatic uveal melanoma","volume":"33","author":"Sagoo","year":"2014","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.jmccpl.2025.100300_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1541-7786.MCR-20-0687","article-title":"The MEK\/ERK Network as a Therapeutic Target in Human Cancer","volume":"19","author":"Barbosa","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","article-title":"Targeting RAS\u2013RAF\u2013MEK\u2013ERK signaling pathway in human cancer: Current status in clinical trials","volume":"10","author":"Song","year":"2023","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.taap.2010.08.010","article-title":"Upregulation of contractile endothelin type B receptors by lipid-soluble cigarette smoking particles in rat cerebral arteries via activation of MAPK","volume":"249","author":"Sandhu","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2010.02.020","article-title":"Up-regulation of bradykinin receptors in rat bronchia via I\u03baB kinase-mediated inflammatory signaling pathway","volume":"634","author":"Lei","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"10.1016\/j.jmccpl.2025.100300_bb0205","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1)","volume":"57","author":"Ye","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112937","article-title":"Endothelial alpha(1)-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK\/p38MAPK signaling pathway","volume":"141","author":"Tian","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"6434","key":"10.1016\/j.jmccpl.2025.100300_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/364249a0","article-title":"Protein kinase C alpha activates RAF-1 by direct phosphorylation","volume":"364","author":"Kolch","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200244","article-title":"Synergistic targeting of the PI3K\/mTOR and MAPK\/ERK pathways in Merkel cell carcinoma","volume":"14","author":"Temblador","year":"2022","journal-title":"Tumour Virus Res"},{"issue":"14","key":"10.1016\/j.jmccpl.2025.100300_bb0225","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1158\/1078-0432.CCR-09-0317","article-title":"In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models","volume":"15","author":"Hoeflich","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100300_bb0230","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.4049\/jimmunol.1003173","article-title":"Two-step binding of transcription factors causes sequential chromatin structural changes at the activated IL-2 promoter","volume":"187","author":"Ishihara","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2202-12-5","article-title":"Human cerebrovascular contractile receptors are upregulated via a B-Raf\/MEK\/ERK-sensitive signaling pathway","volume":"12","author":"Ahnstedt","year":"2011","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2202-14-12","article-title":"MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries","volume":"14","author":"Ansar","year":"2013","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100300_bb0245","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/10717544.2019.1636421","article-title":"Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model","volume":"26","author":"Christensen","year":"2019","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jmccpl.2025.100300_bb0250","article-title":"Switching Off Vascular MAPK Signaling: A Novel Strategy to Prevent Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage","author":"Edvinsson","year":"2024","journal-title":"Transl Stroke Res"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976125000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976125000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:36:11Z","timestamp":1778934971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976125000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S2772976125000194"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2025.100300","relation":{},"ISSN":["2772-9761"],"issn-type":[{"value":"2772-9761","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Independent and synergistic roles of MEK-ERK1\/2 and PKC pathways in regulating functional changes in vascular tissue following flow cessation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2025.100300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100300"}}